RxDoctor Payments DataLook up a doctor →

Bradley Eilerman, MD

Endocrinology, Diabetes & Metabolism · Florence, KYNPI 1841389822

Payments from drug & device makers

$1,861,908in general payments, 2019–2025

Across 2,850 payments — averaging $653.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Corcept Therapeutics$401K
  • Novo Nordisk$320K
  • Lilly USA, LLC$288K
  • Boehringer Ingelheim Pharma GmbH & Co.kg$284K
  • Boehringer Ingelheim International GmbH$198K
  • Dexcom, Inc.$65K
  • plus $307K from 54 others
$8,678in research payments, 2019–2025

Across 10 payments — averaging $867.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Recordati_rare_diseases_inc.$7K
  • Eli Lilly$2K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Corcept Therapeutics399$400,615
Novo Nordisk598$320,009
Lilly USA, LLC532$287,651
Boehringer Ingelheim Pharma GmbH & Co.kg16$284,040
Boehringer Ingelheim International GmbH45$197,905
Dexcom, Inc.120$64,518
AstraZeneca(2 entities)83$46,207
Novo Nordisk AS27$41,941
Bayer60$36,772
Eli Lilly2$34,925
Boehringer Ingelheim98$32,752
Sanofi-aventis U.S. LLC83$26,016
Ascendis Pharma Endocrinology Inc21$24,590
AbbVie41$9,637
Merck24$7,436
Johnson & Johnson25$7,336
Recordati_rare_diseases_inc.30$7,245
Shire North American Group Inc11$5,635
Abbott79$5,088
Xeris Pharmaceuticals, Inc.33$4,212
Medtronic(2 entities)92$3,272
Clarus Therapeutics Inc.12$2,464
Biomarin Pharmaceutical Inc.1$2,457
Zealand Pharma US, Inc.4$1,635
Amgen(2 entities)84$1,131
IBSA Pharma Inc.19$829
Insulet Corporation30$537
Mannkind Corporation37$477
Amarin Pharma, Inc.29$441
Novartis25$440
Antares Pharma, Inc.20$333
Radius Health, Inc.17$288
Exact Sciences3$271
Lifescan, Inc.15$247
Pfizer16$227
BETA Bionics, Inc.4$190
BD8$162
Regeneron Healthcare Solutions, Inc.9$139
Neurocrine Biosciences, Inc.5$135
Takeda Pharmaceuticals U.S.A., Inc.1$125
Astellas Pharma US Inc6$125
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC7$119
Esperion Therapeutics, Inc.7$104
Eisai Inc.5$94
Amryt Pharma Holdings Ltd5$82
Rhythm Pharmaceuticals, Inc.4$76
Cequr Corporation2$74
Valeritas, Inc.5$73
Tandem Diabetes Care, Inc.5$71
Tolmar, Inc.3$60
Endo Pharmaceuticals Inc.4$56
Kyowa Kirin, Inc.3$54
Sequel Med Tech, LLC2$47
Amneal Pharmaceuticals LLC3$47
Averitas Pharma Inc.2$45
EUSA Pharma (US) LLC3$40
Grifols USA, LLC2$38
Verity Pharmaceuticals Inc.2$36
Halozyme Inc2$30
Vivus LLC2$29

How this compares

$1,861,908 in reported general payments places this provider in the 95th percentile of 90 endocrinology, diabetes & metabolism providers in Kentucky.

See all endocrinology, diabetes & metabolism providers in Kentucky →

Medicare billing

Part B allowed, 2024
$96,027
Medicare patients
378
Services billed
3,999

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Florence

See the full list for Kentucky →

Where these figures come from

Is this you, or does something look wrong? →